Clinical trial
The Impact of Adding Suzetrigine to Multimodal Analgesia for Minimally Invasive Hysterectomy
NCT07836010 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Adding Suzetrigine to Multimodal Analgesia for Minimally Invasive Hysterectomy
- Lead sponsor
- Duke University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- February 29, 2028
- Enrollment
- 123 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.